Mandel Diagnostics

Mandel Diagnostics has developed an automated screening device that detects age-related macular degeneration, the leading cause of vision loss, enabling eye doctors to apply new therapies approved in 2024 instead of referring patients to surgeons. This saves payers up to $8,000 per patient annually compared to late-stage treatments while helping patients preserve their vision into their 90s and beyond.